Masako Ichihara

2.5k total citations
18 papers, 2.1k citations indexed

About

Masako Ichihara is a scholar working on Biomaterials, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Masako Ichihara has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomaterials, 12 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Masako Ichihara's work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (9 papers) and Immunotherapy and Immune Responses (4 papers). Masako Ichihara is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (9 papers) and Immunotherapy and Immune Responses (4 papers). Masako Ichihara collaborates with scholars based in Japan, Egypt and Albania. Masako Ichihara's co-authors include Tatsuhiro Ishida, Hiroshi Kiwada, Kenji Irimura, Xinyu Wang, Kenji Yamamoto, Junji Kimura, Eiji Majima, Xinyu Wang, Xinyu Wang and Taro Shimizu and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Toxicology.

In The Last Decade

Masako Ichihara

18 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Ichihara Japan 16 1.2k 1.2k 513 457 371 18 2.1k
François Fay United States 21 611 0.5× 569 0.5× 553 1.1× 362 0.8× 311 0.8× 39 1.7k
Guankui Wang United States 21 812 0.7× 577 0.5× 546 1.1× 373 0.8× 91 0.2× 38 1.7k
E.T.M. Dams Netherlands 15 690 0.6× 553 0.5× 286 0.6× 191 0.4× 183 0.5× 24 1.3k
Jindřich Kopeček United States 24 1.3k 1.1× 1.1k 1.0× 729 1.4× 99 0.2× 143 0.4× 49 2.7k
Christien Oussoren Netherlands 21 529 0.4× 923 0.8× 250 0.5× 366 0.8× 318 0.9× 32 1.8k
Wenxue Ma United States 26 453 0.4× 1.1k 0.9× 352 0.7× 722 1.6× 246 0.7× 84 2.5k
Troy O. Harasym Canada 21 915 0.7× 1.3k 1.1× 483 0.9× 174 0.4× 119 0.3× 45 2.2k
Alberto Gabizon Israel 16 840 0.7× 754 0.6× 356 0.7× 96 0.2× 140 0.4× 23 1.6k
Leaf Huang United States 25 743 0.6× 1.2k 1.0× 691 1.3× 481 1.1× 112 0.3× 45 2.2k
Dorit Goren Israel 18 1.5k 1.2× 1.3k 1.1× 661 1.3× 85 0.2× 162 0.4× 19 2.4k

Countries citing papers authored by Masako Ichihara

Since Specialization
Citations

This map shows the geographic impact of Masako Ichihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Ichihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Ichihara more than expected).

Fields of papers citing papers by Masako Ichihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Ichihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Ichihara. The network helps show where Masako Ichihara may publish in the future.

Co-authorship network of co-authors of Masako Ichihara

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Ichihara. A scholar is included among the top collaborators of Masako Ichihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Ichihara. Masako Ichihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Suzuki, Takuya, Masako Ichihara, Kenji Hyodo, et al.. (2014). Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin. International Journal of Pharmaceutics. 476(1-2). 205–212. 61 indexed citations
2.
Lila, Amr S. Abu, Masako Ichihara, Taro Shimizu, Tatsuhiro Ishida, & Hiroshi Kiwada. (2013). <i>Ex-Vivo</i>/<i>in-Vitro</i> Anti-polyethylene Glycol (PEG) Immunoglobulin M Production from Murine Splenic B Cells Stimulated by PEGylated Liposome. Biological and Pharmaceutical Bulletin. 36(11). 1842–1848. 24 indexed citations
3.
Lila, Amr S. Abu, et al.. (2012). Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application. International Journal of Pharmaceutics. 438(1-2). 176–183. 35 indexed citations
4.
Suzuki, Takuya, Masako Ichihara, Kenji Hyodo, et al.. (2012). Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs. International Journal of Pharmaceutics. 436(1-2). 636–643. 106 indexed citations
5.
Lila, Amr S. Abu, Tomoko Okada, Yusuke Doi, et al.. (2012). Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: Synergy or antagonism?. International Journal of Pharmaceutics. 426(1-2). 263–270. 8 indexed citations
6.
Ichihara, Masako, et al.. (2012). Anti-PEG IgM Production via a PEGylated Nano-Carrier System for Nucleic Acid Delivery. Methods in molecular biology. 948. 35–47. 17 indexed citations
7.
Shimizu, Taro, Masako Ichihara, Yasuo Yoshioka, et al.. (2012). Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response. Biological and Pharmaceutical Bulletin. 35(8). 1336–1342. 79 indexed citations
9.
Ichihara, Masako, et al.. (2010). Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats. Pharmaceutics. 3(1). 1–11. 134 indexed citations
10.
Ishida, Tatsuhiro, Masako Ichihara, Xinyu Wang, & Hiroshi Kiwada. (2006). Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. Journal of Controlled Release. 115(3). 243–250. 227 indexed citations
11.
Yamano, Tetsuo, Masako Ichihara, Mitsuru Shimizu, Tsutomu Noda, & Yuji Tsujimoto. (2006). Immunomodulatory effects of mono-, di-, and trimethylphenols in mice. Toxicology. 232(1-2). 132–137. 3 indexed citations
12.
Ishida, Tatsuhiro, Masako Ichihara, Xinyu Wang, et al.. (2006). Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. Journal of Controlled Release. 112(1). 15–25. 464 indexed citations
13.
Wang, Xinyu, Tatsuhiro Ishida, Masako Ichihara, & Hiroshi Kiwada. (2005). Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats. Journal of Controlled Release. 104(1). 91–102. 65 indexed citations
15.
Ishida, Tatsuhiro, et al.. (2004). Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. Journal of Controlled Release. 95(3). 403–412. 103 indexed citations
16.
Ishida, Tatsuhiro, et al.. (2003). Accelerated clearance of a second injection of PEGylated liposomes in mice. International Journal of Pharmaceutics. 255(1-2). 167–174. 148 indexed citations
17.
Ishida, Tatsuhiro, et al.. (2003). Accelerated clearance of PEGylated liposomes in rats after repeated injections. Journal of Controlled Release. 88(1). 35–42. 276 indexed citations
18.
Ishida, Tatsuhiro, et al.. (2002). The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study.. PubMed. 7(2). 286–286. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026